Assessing Quality of Life in Hemodialysis Patients in Kazakhstan: A Cross-Sectional Study
Open Access
- 16 July 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 5021
Abstract
Background: The Kidney Disease and Quality of Life Short Form (KDQOL-SF™ 1.3) is widely used to assess health-related quality of life (HRQoL) in patients with end-stage renal disease. However, no prior validation had been conducted in Kazakhstan, where both Kazakh and Russian are commonly spoken. This study aimed to validate the Kazakh and Russian versions of the KDQOL-SF™ 1.3 and to identify predictors of HRQoL among hemodialysis patients in Kazakhstan. Methods: A cross-sectional survey was conducted among 217 adult hemodialysis patients from February to April 2025 using a mixed-methods approach (in-person interviews and online data collection). Psychometric testing included Cronbach’s alpha, floor and ceiling effect analysis, and Pearson correlations with self-rated overall health. Multiple linear regression was used to identify predictors of the Kidney Disease Component Summary (KDCS), Physical Component Summary (PCS), and Mental Component Summary (MCS) scores. Results: Both language versions demonstrated acceptable to excellent internal consistency (Cronbach’s α = 0.692–0.939). Most subscales were significantly correlated with self-rated health, supporting construct validity. Regression analyses revealed that greater satisfaction with care, better economic well-being, and more positive dialysis experiences were significant predictors of higher KDCS and MCS scores. Lower PCS scores were associated with female gender, comorbidities, and financial burden. Importantly, financial hardship and access challenges emerged as strong negative influences on HRQoL, underscoring the role of socioeconomic and care-related factors in patient well-being. Conclusions: The KDQOL-SF™ 1.3 is a valid and reliable tool for assessing quality of life among Kazakh- and Russian-speaking hemodialysis patients in Kazakhstan. Integrating this instrument into routine clinical practice may facilitate more personalized, patient-centered care and help monitor outcomes beyond traditional clinical indicators. Addressing economic and access-related barriers has the potential to significantly improve both physical and mental health outcomes in this vulnerable population.Keywords
Funding Information
- Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan (BR21882206)
This publication has 34 references indexed in Scilit:
- Quality of Life in Patients with CKD With Catastrophic Health Care Expenditures: A National Study From ThailandKidney Medicine, 2025
- Relational skills of nephrology and dialysis nurses in clinical care settings: A scoping review and stakeholder consultationNurse Education in Practice, 2024
- The Burden of Travel-Time and Distance Traveled for Hemodialysis Patients in Australian Major City AreasKidney International Reports, 2023
- Prevalence and Disease Burden of Chronic Kidney Disease2019
- Transcultural adaptation and validation of the Mexican version of the kidney disease questionnaire KDQOL-SF36 version 1.3Quality of Life Research, 2016
- Measurement Properties of the Chinese Version of the Kidney Disease Quality of Life-Short Form (KDQOL-SF™) in End-Stage Renal Disease Patients With Poor Prognosis in SingaporeJournal of Pain and Symptom Management, 2012
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007
- Determining the Basic Psychometric Properties of the Greek KDQOL-SFTMQuality of Life Research, 2005
- Reliability testing of the Danish version of the Kidney Disease Quality of Life Short Form™Scandinavian Journal of Urology and Nephrology, 2005
- Development of the Kidney Disease Quality of Life (KDQOLTM) InstrumentQuality of Life Research, 1994